ClinDatrix partners with Dedicated Phase I on projects that require a dedicated Phase I facility.
Dedicated Phase I operates both Phase I and Phase II-IV sites with board-certified Investigators. There are more than 480,000 possible study participants in their database. The 21,000 sq. ft. overnight facility is located in downtown Phoenix, Arizona within a few miles from ASU and U of A medical schools. The 80-bed facility is specifically designed to blend state-of-the-art technology with modern comfort for both mixed and single population studies. Services include study concept and design, Phase I-IIa bioequivalence studies, and Phase I-IV special population trials with rapid study enrollment, high subject retention and meticulous data.